Johnson & Johnson Stock Rises After Guggenheim Analyst Raises Price Target

Johnson & Johnson (J&J) stock rose by 3.4% on Friday after analyst Vamil Divan from Guggenheim raised his price target for the company to $270 per share, indicating potential growth of over 10%. The move comes ahead of J&J's Q2 earnings report due in July.

By Rich Smith, The Motley Fool Fri, June 26, 2026 at 7:59 PM GMT+3 3 min read · Yahoo Finance · June 26, 2026, 16:59 UTC

Johnson & Johnson Stock Rises After Guggenheim Analyst Raises Price Target

Tickers: $JNJ $NVDA

Topics: Guggenheim analyst Johnson & Johnson price target increase

Read the full article at Yahoo Finance

More World news

Al Mouj Muscat Receives Three Architectural Awards at International and Arabian Property Awards 2026 PR Newswire · November 12, 2026, 17:01 UTC
SoftBank Reports $7.1 Billion Quarterly Loss Driven by Natural Gas Turbine Over-Ordering TechCrunch · November 12, 2026, 17:00 UTC
PayPal and Kiva Renew Long-Term Partnership to Support Global Microloans PR Newswire · November 12, 2026, 17:00 UTC
Tesla to Discontinue Cybertruck Production by Summer 2027 to Prioritize Cybercab The Verge · November 12, 2026, 17:00 UTC
Absci Reports Q3 2026 Financial Results and Clinical Updates for ABS-201 Motley Fool · November 12, 2026, 16:54 UTC
Acurx Pharmaceuticals Reports Q3 2026 Financial Results and Initiates PATHFINDER Trial Enrollment Motley Fool · November 12, 2026, 16:54 UTC
Fermi Inc. Reports Q3 2026 Net Loss of $141.6 Million Amid Infrastructure Expansion Motley Fool · November 12, 2026, 16:54 UTC
Google Wallet Introduces Digital Home Key Support via Aliro Standard The Verge · November 12, 2026, 16:56 UTC
Analyst Ming-Chi Kuo Suggests Nvidia CEO Resignation May Have Limited Near-Term Stock Impact Seeking Alpha · November 12, 2026, 16:53 UTC
Solo Brands Lowers Net Sales Outlook While Projecting 2026 Adjusted EBITDA Growth Seeking Alpha · November 12, 2026, 16:50 UTC